Wambolt & Associates’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.16M Sell
25,647
-1,374
-5% -$169K 1.06% 28
2025
Q1
$2.96M Buy
27,021
+443
+2% +$48.6K 1.01% 32
2024
Q4
$2.59M Sell
26,578
-5,011
-16% -$488K 0.83% 38
2024
Q3
$3.62M Buy
31,589
+1,399
+5% +$160K 0.99% 30
2024
Q2
$3.22M Buy
30,190
+1,965
+7% +$209K 0.93% 32
2024
Q1
$2.71M Buy
28,225
+3,425
+14% +$328K 0.81% 38
2023
Q4
$2.5M Buy
24,800
+3,480
+16% +$351K 0.82% 31
2023
Q3
$2.16M Buy
21,320
+1,899
+10% +$193K 0.79% 33
2023
Q2
$1.96M Buy
19,421
+742
+4% +$74.9K 0.7% 36
2023
Q1
$1.73M Buy
18,679
+729
+4% +$67.4K 0.61% 47
2022
Q4
$1.63M Buy
17,950
+552
+3% +$50.1K 0.63% 48
2022
Q3
$1.32M Buy
17,398
+179
+1% +$13.6K 0.56% 61
2022
Q2
$1.46M Buy
17,219
+904
+6% +$76.4K 0.59% 58
2022
Q1
$1.43M Buy
16,315
+738
+5% +$64.7K 0.52% 70
2021
Q4
$1.36M Buy
15,577
+1,690
+12% +$148K 0.49% 70
2021
Q3
$1.14M Buy
13,887
+936
+7% +$76.8K 0.46% 82
2021
Q2
$1.19M Sell
12,951
-370
-3% -$33.9K 0.5% 69
2021
Q1
$1.15M Buy
13,321
+819
+7% +$70.5K 0.6% 63
2020
Q4
$1.18M Buy
12,502
+560
+5% +$52.9K 0.71% 43
2020
Q3
$1.04M Buy
11,942
+517
+5% +$44.9K 0.78% 39
2020
Q2
$998K Buy
11,425
+787
+7% +$68.7K 0.78% 35
2020
Q1
$877K Buy
10,638
+496
+5% +$40.9K 0.91% 32
2019
Q4
$960K Buy
10,142
+811
+9% +$76.8K 0.73% 41
2019
Q3
$811K Sell
9,331
-167
-2% -$14.5K 0.67% 48
2019
Q2
$867K Buy
9,498
+284
+3% +$25.9K 0.73% 40
2019
Q1
$689K Buy
9,214
+680
+8% +$50.8K 0.63% 47
2018
Q4
$656K Buy
+8,534
New +$656K 0.72% 37